vincristine

OBJECTIVE To study the physical and chemical stability of vincristine sulfate - blank liposomes.

目的考察三瓶裝硫酸長春新堿脂質體中空白脂質體的物理、化學穩定性.

互聯網

FDA approves vincristine, a sister drug to vinblastine.

1963年,FDA批準長春花堿的姊妹藥,長春新堿.

互聯網

CONCLUSION It is appropriate a 3 - bottled paekage for vincristine sulfate liposome, and which improves its stability.

結論硫酸長春新堿脂質體適合制成三瓶分裝制劑, 有利于提高藥物穩定性.

互聯網

Conclusion CyA, which is safe and effective, gains an advantage over vincristine in the recent treatment of ITP.

結論CyA對難治性ITP的近期療效明顯優于長春新堿,毒副作用較少, 是一種安全有效的治療方法.

互聯網

The combined effect of 1,2:5,6 - dianhydrogalactitol ( DAG ) and vincristine ( VCR ) on L _ ( 1210 ) leukemia was studied.

去水衛矛醇 ( DAG ) 與長春新堿 ( VCR ) 聯合使用,對小鼠淋巴細胞白血病L_ ( 1210 ) 有協同療效,療效強度決定于給藥方案和劑量.

互聯網

Objective To study the method of microwave combined with vincristine for purging leukemic cells in vitro.

研究一種較好的微波和長春新堿的聯合方法,用于白血病細胞的體外凈化.

互聯網